Drugs / TAK-536TCH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02348658 | Jan → Mar 2015 | hypertensive disorder | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-536TCH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02348658 ↗ |
| Route | Oral | “single oral dose” NCT02348658 ↗ |